Gujarat Kidney and Super Speciality Ltd Unveils IPO Details with Rs 251 Crore Goal in Sight

Gujarat Kidney and Super Speciality Ltd has set a price band of Rs 108-114 per share for its Rs 251 crore IPO, open from December 22-24. Funds will be used for acquisitions, expansion, and debt repayment. The company operates seven hospitals in Gujarat, focusing on secondary and tertiary care.

Healthcare firm Gujarat Kidney and Super Speciality Ltd announced a price range of Rs 108-114 per share for its anticipated Rs 251 crore Initial Public Offering (IPO) set for December 22-24. This marks the company's debut in the public offering landscape.

The funds raised, expected to reach Rs 250.8 crore at the maximum price, are intended for significant expansions, including acquiring Parekhs Hospital in Ahmedabad and partial payment for Ashwini Medical Centre. Additionally, the company plans to establish a new hospital in Vadodara, purchase robotics equipment, and support other corporate needs.

With seven multispeciality hospitals in Gujarat, the company eyes further growth. Financial reports show a revenue of Rs 40.24 crore and a net profit of Rs 9.5 crore for the fiscal year ending March 2025. Nirbhay Capital Services will manage the books for this public issue.

(With inputs from agencies.)